Surprisingly, our findings ruled out a role for classical anti-tumor effector cells such as CD8+ T cells and NK cells, as mice depleted of either of these subsets still exhibited dramatic reductions in tumor burden following the loss of the GFAP+ glia. This evidence concerns the gene CD8A and neoplasm.